Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, OH
SEC filing record 1 source field available
Fiscal year end
31 December
NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

SEC filing history

Showing 726-750 of 949 matching filings.

Per page
25
Current page
30
424B3 File 333-173752

PROSPECTUS SUPPLEMENT

Filing date
31 Dec 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
19 Dec 2012
Reporting date
13 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
03 Dec 2012
Reporting date
27 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Nov 2012
Reporting date
27 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-35076

FORM 8-K/A

Filing date
14 Nov 2012
Reporting date
13 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
13 Nov 2012
Reporting date
13 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Nov 2012
Reporting date
04 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
09 Nov 2012
Reporting date
26 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
09 Nov 2012
Reporting date
08 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Nov 2012
Reporting date
01 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 Nov 2012
Reporting date
01 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
01 Nov 2012
Reporting date
30 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-184173

PROSPECTUS

Filing date
22 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-184173

EFFECT filing

Filing date
17 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
11 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-184173

FORM S 3/A

Filing date
11 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
11 Oct 2012
Reporting date
10 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Oct 2012
Reporting date
01 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
10 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-184173

FORM S-3

Filing date
28 Sep 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Sep 2012
Reporting date
26 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-35076

CT ORDER filing

Filing date
27 Sep 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

CURRENT REPORT

Filing date
21 Sep 2012
Reporting date
20 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .